Projects per year
Personal profile
Education
- 2007-2012 Ph.D., Graduate Institute of Medical Sciences, Taipei Medical University
- 2006-2007 M.S., School of Medicine, College of Medicine, Taipei Medical University
- 2002-2006 B.S., Department of Optometry, Chung Shan Medical University
Experience
- 2017.11- Assistant Professor, Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University
- 2016.03- Assistant Professor, Department of Pharmacology, College of Medicine, Taipei Medical University
- 2012.01-2015.04 Postdoctoral Research Fellow, School of Nutrition and Health Sciences, Taipei Medical University
- Researcher, Department of Medical Research, Taipei Medical University Hospital
Research Interests
- 藥理
- 毒理
Fingerprint Dive into the research topics where Wan-Jung Lu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Development of Protease-Activated Receptor 4 Antagonists as Novel Antithrombotic Drugs
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
在體外及活體實驗中探討aldose reductase在血小板活化過程中的角色
3/1/19 → 2/1/20
Project: C - Project of Alliance › s - Shin Kong Wu Ho-Su Memorial Hospital
細胞膜連結支架蛋白Shank3在大腦缺血反應中的病理生理角色-SHANK3於缺氧所誘發的神經興奮性損傷中所扮演的角色與機制探討
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
To Study the Role of Multidrug Resistance Protein 4 on Induction of Aspirin Resistance in Type 2 Diabetes Mellitus
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology
To Study the Role of Multidrug Resistance Protein 4 on Induction of Aspirin Resistance in Type 2 Diabetes Mellitus
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output
Author Correction: A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies (Scientific Reports, (2017), 7, 1, (9556), 10.1038/s41598-017-09695-z)
Hsia, C. H., Velusamy, M., Sheu, J. R., Khamrang, T., Jayakumar, T., Lu, W. J., Lin, K. H. & Chang, C. C., Dec 1 2020, In : Scientific Reports. 10, 1, 1743.Research output: Contribution to journal › Comment/debate
Open Access
Erratum: Structure-Activity Relationship of Three Synthesized Benzimidazole-Based Oligosaccharides in Human Platelet Activation (International Journal of Molecular Medicine (2017) 40 (1520-1528) DOI: 10.3892/ijmm.2017.3133)
Chang, Y., Hsu, W. H., Yang, W. B., Jayakumar, T., Lee, T. Y., Sheu, J. R., Lu, W. J. & Li, J. Y., Feb 1 2020, In : International Journal of Molecular Medicine. 45, 2, 1 p.Research output: Contribution to journal › Comment/debate
Open Access
Embelin as a Novel Inhibitor of PKC in the Prevention of Platelet Activation and Thrombus Formation
Li, J. Y., Chen, R. J., Huang, L. T., Lee, T. Y., Lu, W. J. & Lin, K. H., Oct 18 2019, In : Journal of Clinical Medicine. 8, 10Research output: Contribution to journal › Article
New therapeutic strategy of hinokitiol in haemorrhagic shock-induced liver injury
Lu, W-J., Lin, K-H., Tseng, M-F., Yuan, K-C., Huang, H-C., Sheu, J-R. & Chen, R-J., Mar 1 2019, In : Journal of Cellular and Molecular Medicine. 23, 3, p. 1723-1734 12 p.Research output: Contribution to journal › Article
Suppression of human platelet activation via integrin αiibβ3 outside-in independent signal and reduction of the mortality in pulmonary thrombosis by auraptene
Hsia, C. W., Tsai, C. L., Sheu, J. R., Lu, W. J., Hsia, C. H., Velusamy, M., Jayakumar, T. & Li, J. Y., Nov 2 2019, In : International Journal of Molecular Sciences. 20, 22, 5585.Research output: Contribution to journal › Article
Open Access